Liang Zhao

Director/Board Member chez MICROPORT CARDIOFLOW MEDTECH CORPORATION

Fortune : 41 629 $ au 31/03/2024

45 ans

Health Technology

Consumer Services

Profil

Liang Zhao is currently the Director at Shanghai MicroPort CardioFlow Medtech Co., Ltd.
and the Executive Director & VP-Total Solutions at MicroPort CardioFlow Medtech Corp.
Prior to his current roles, he obtained his undergraduate degree from Nanjing University in 2002.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
MICROPORT CARDIOFLOW MEDTECH CORPORATION 0,01%	11/07/2023	288 332 ( 0,01% )	41 629 $	31/03/2024

Postes actifs de Liang Zhao

Sociétés	Poste	Début
MICROPORT CARDIOFLOW MEDTECH CORPORATION	Director/Board Member	26/05/2022
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023.	Director/Board Member	26/05/2022

Tous les postes actifs de Liang Zhao

Formation de Liang Zhao

Nanjing University

Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Liang Zhao

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées	1
MICROPORT CARDIOFLOW MEDTECH CORPORATION	Health Technology

Entreprise privées	1
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023.	Health Technology